Global Gastric Volvulus Treatment Market Size and Forecast 2023-2032| Sawai Pharmaceutical Co Ltd, PAI Pharma, Sun Pharmaceutical Industries Ltd, ANI Pharmaceuticals Inc., Fresenius SE and Co KGaA,

The Gastric Volvulus Treatment Global Market Report 2023, provides comprehensive information on the gastric volvulus treatment market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Gastric Volvulus Treatment Market’s Growth:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

As per The Business Research Company’s Gastric Volvulus Treatment Global Market Report 2023, the global gastric volvulus treatment market size is expected to grow from $24.19 billion in 2022 to $25.73 billion in 2023 at a compound annual growth rate (CAGR) of 6.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global gastric volvulus treatment market size is expected to reach $31.8 billion in 2027 at a CAGR of 5.4%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Product innovations are a key trend gaining popularity in the gastric volvulus treatment market. Major companies operating in the market are introducing innovative products to sustain their position in the gastric volvulus treatment market. For instance, in December 2020, 9 Meters Biopharma, Inc., a US-based clinical-stage company focused on rare and unmet needs in gastroenterology, launched NM-002, a proprietary long-acting GLP-1, in a Phase 1b/2a trial for short bowel syndrome. NM-002 is designed as a long-acting injectable GLP-1 receptor agonist that utilizes proprietary XTEN technology to extend its circulating half-life. This is designed specifically to slow digestive transit time in SBS patients by reducing upper GI motility and improving the chronic diarrhea associated with a shortened intestine.

The gastric volvulus treatment market is segmented:

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

North America was the largest region in the gastric volvulus treatment market in 2022.

The table of contents in TBRC’s gastric volvulus treatment market report includes:

1. Executive Summary

2. Gastric Volvulus Treatment Market Characteristics

3. Gastric Volvulus Treatment Market Trends And Strategies

4. Gastric Volvulus Treatment Market – Macro Economic Scenario

5. Gastric Volvulus Treatment Market Size And Growth

.

.

.

26. Africa Gastric Volvulus Treatment Market

27. Gastric Volvulus Treatment Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Gastric Volvulus Treatment Market

29. Gastric Volvulus Treatment Market Future Outlook and Potential Analysis

30. Appendix

Top Major Players:

• Sawai Pharmaceutical Co Ltd
• PAI Pharma
• Sun Pharmaceutical Industries Ltd
• ANI Pharmaceuticals Inc
• Fresenius SE and Co KGaA

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model